AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Summary
Transcript
Episode notes
Devi's is gearing up to meet the demand for drugs that will soon go off-patent in the next three years. At one point, the stock was trading at 50 times its earnings. Even a small hurdle can skewer the share price. The business is probably still solid, but investors ran ahead of themselves.
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode